FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Pharmacol Ther / Concentrations, pharmacokinetics and selected pharmacodynami...
Journal of veterinary pharmacology and therapeutics2023; 46(4); 238-249; doi: 10.1111/jvp.13122

Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses.

Abstract: The metabolism and pharmacokinetics of intravenous (i.v.) morphine in the horse have been described; however, administration of therapeutic doses has also been associated with neuroexcitation and adverse gastrointestinal effects. In this study, we hypothesized that oral administration would lead to comparable concentrations of morphine and its presumed active metabolite, morphine 6-glucuronide (M6G) without the adverse effects associated with i.v. administration. Eight horses were administered a single i.v. dose of 0.2 mg/kg morphine and oral doses of 0.2, 0.6, and 0.8 mg/kg of morphine in a four-way balanced crossover design, with a 2-week washout period between doses. Concentrations of morphine and metabolites were determined, and pharmacokinetic parameters determined. Physiologic and behavioral outcomes including the number of steps taken, changes in heart rate, and gastrointestinal borborygmi were assessed. Oral administration of morphine resulted in higher concentrations of morphine metabolites, including M6G (C : 11.6-37.8 ng/mL (0.6 mg/kg); 15.8-42.6 ng/mL (0.8 mg/kg)), compared with i.v. Bioavailability was 36.5%, 27.6% and 28.0% for 0.2, 0.6 and 0.8 mg/kg, respectively. Behavioral and physiologic changes were noted in all groups but were less prominent with oral compared with i.v. administration. Results of the current study are encouraging for further study, specifically anti-nociceptive effects of morphine following oral administration.
© 2023 John Wiley & Sons Ltd.
Get Full Text
Publication Date: 2023-03-08 PubMed ID: 36883679DOI: 10.1111/jvp.13122Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates how orally administering morphine to horses impacts the concentration of the drug and its active metabolites. It’s found that oral administration can lead to comparable drug concentrations to intravenous administration but with fewer adverse effects.

Study Design

The study followed a controlled and detailed setup. Here are the key elements of the experiment:

  • The researchers examined the effect of oral morphine administration on eight horses. They compared this with the effects of intravenous (i.v.) administration.
  • The horses were given a single i.v. dose of morphine measuring 0.2 mg/kg. Oral doses measuring 0.2, 0.6, and 0.8 mg/kg were also administered. The different drug administrations followed a four-way balanced crossover design, with a two-week washout period between each dose. This design ensures that each horse could serve as its own control, which helps minimize the influence of individual variations among the test subjects.
  • The concentrations of morphine and its metabolites were then measured and the pharmacokinetics or drug behavior within the body was determined.
  • The researchers also monitored changes in behaviors and physiological parameters such as heart rate, number of steps taken, and gastrointestinal sounds or ‘borborygmi’.

Findings

The research results provided notable insights into the effects of oral morphine administration in horses. Here are some of the primary findings:

  • Oral administration of morphine findings revealed higher concentrations of morphine metabolites, particularly M6G. The concentrations ranged from 11.6-37.8 ng/mL for a 0.6 mg/kg dose and 15.8-42.6 ng/mL for a 0.8 mg/kg dose.
  • The bioavailability of morphine, which refers to the proportion of drug that enters the circulation and could have an active effect, was found to be 36.5% for a 0.2 mg/kg dose, 27.6% for a 0.6 mg/kg dose and 28.0% for a 0.8 mg/kg dose. These rates indicate that a significant amount of the drug is absorbed and used by the body.
  • Behavioral and physiological changes were observed in the horses. But such changes were less prominent with oral administration compared to intravenous administration, suggesting that oral administration might cause fewer side effects.

Implications

The results of this study provide promising implications for future research and potential medical usage. The observation that oral administration of morphine can lead to comparable drug and metabolite concentrations as intravenous administration, but with fewer behavioral and physiological changes, implies it might be a preferable route of administration. This finding encourages further examination, specifically regarding the pain-relieving or ‘anti-nociceptive’ effects of morphine when administered orally.

Cite This Article

APA
Poth MKM, McKemie DS, Traynham M, Kass PH, Knych HK. (2023). Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses. J Vet Pharmacol Ther, 46(4), 238-249. https://doi.org/10.1111/jvp.13122

Publication

Journal of veterinary pharmacology and therapeutics
ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 46
Issue: 4
Pages: 238-249

Researcher Affiliations

Poth, Meghan K M
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
McKemie, Daniel S
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
Traynham, Megan
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
Kass, Philip H
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
Knych, Heather K
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.

MeSH Terms

  • Animals
  • Administration, Oral
  • Analgesics, Opioid / pharmacology
  • Biological Availability
  • Horses
  • Morphine / pharmacology
  • Morphine Derivatives
  • Cross-Over Studies

Grant Funding

  • T35 OD010956 / ODCDC CDC HHS
  • T35 OD010956 / ODCDC CDC HHS

References

This article includes 31 references
  1. Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: Resolving the two. Anaesthesia and Intensive Care 40(2), 216-235.
    doi: 10.1177/0310057x1204000204google scholar: lookup
  2. Bartlett SE, Cramond T, Smith MT. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences 54(10), 687-694.
    doi: 10.1016/0024-3205(94)00552-4google scholar: lookup
  3. Bennett RC, Steffey EP. Use of opioids for pain and anesthetic management in horses. The Veterinary Clinics of North America. Equine Practice 18(1), 47-60.
    doi: 10.1016/s0749-0739(02)00011-1google scholar: lookup
  4. Bowsher D. Paradoxical pain. BMJ (Clinical Research Ed.) 306(6876), 473-474.
    doi: 10.1136/bmj.306.6876.473google scholar: lookup
  5. Combie J, Shults T, Nugent EC, Dougherty J, Tobin T. Pharmacology of narcotic analgesics in the horse: Selective blockade of narcotic-induced locomotor activity. American Journal of Veterinary Research 42(5), 716-721.
  6. Dohoo S, Tasker R. Pharmacokinetics of oral morphine sulfate in dogs: A comparison of sustained release and conventional formulations. Canadian Journal of Veterinary Research 61(4), 251-255.
  7. Dönselmann Im Sande P, Hopster K, Kästner S. [Effects of morphine, butorphanol and levomethadone in different doses on thermal nociceptive thresholds in horses]. Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere 45(2), 98-106.
    doi: 10.15653/tpg-160655google scholar: lookup
  8. Duke-Novakovski T, Jimenez CP, Fujiyama M, Beazley SG. Plasma histamine concentrations in horses administered sodium penicillin, guaifenesin-xylazine-ketamine and isoflurane with morphine or butorphanol. Veterinary Anaesthesia and Analgesia 48(1), 17-25.
    doi: 10.1016/j.vaa.2020.10.003google scholar: lookup
  9. Figueiredo JP, Muir WW, Sams R. Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses. American Journal of Veterinary Research 73(6), 799-808.
    doi: 10.2460/ajvr.73.6.799google scholar: lookup
  10. Hamamoto-Hardman BD, Steffey EP, McKemie DS, Kass PH, Knych HK. Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses. BMC Veterinary Research 16(1), 368.
    doi: 10.1186/s12917-020-02564-4google scholar: lookup
  11. Hamamoto-Hardman BD, Steffey EP, Weiner D, McKemie DS, Kass P, Knych HK. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses. Journal of Veterinary Pharmacology and Therapeutics 42(4), 401-410.
    doi: 10.1111/jvp.12759google scholar: lookup
  12. Hasselström J, Säwe J. Morphine pharmacokinetics and metabolism in humans. Clinical Pharmacokinetics 24(4), 344-354.
    doi: 10.2165/00003088-199324040-00007google scholar: lookup
  13. Janicki PK. Pharmacology of morphine metabolites. Current Pain and Headache Reports 1, 264-270.
  14. Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: A quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. British Journal of Anaesthesia 113(6), 935-944.
    doi: 10.1093/bja/aeu186google scholar: lookup
  15. Knych HK, Kanarr K, Fang Y, McKemie DS, Kass PH. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses. Veterinary Anaesthesia and Analgesia 49, 634-644.
  16. Knych HK, Steffey EP, McKemie DS. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses. Journal of Veterinary Pharmacology and Therapeutics 37(4), 374-381.
    doi: 10.1111/jvp.12098google scholar: lookup
  17. Ladebo L, Olesen AE. Do genes affect morphine response?. Pharmacogenomics 18(17), 1553-1555.
    doi: 10.2217/pgs-2017-0138google scholar: lookup
  18. Lötsch J, Weiss M, Ahne G, Kobal G, Geisslinger G. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers. Anesthesiology 90(4), 1026-1038.
    doi: 10.1097/00000542-199904000-00016google scholar: lookup
  19. Oldendorf WH, Hyman S, Braun L, Oldendorf SZ. Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 178(4064), 984-986.
    doi: 10.1126/science.178.4064.984google scholar: lookup
  20. Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clinical Pharmacology and Therapeutics 47(1), 12-19.
    doi: 10.1038/clpt.1990.2google scholar: lookup
  21. Romberg R, van Dorp E, Hollander J, Kruit M, Binning A, Smith T, Dahan A. A randomized, double-blind, placebo-controlled pilot study of IV morphine-6-glucuronide for postoperative pain relief after knee replacement surgery. The Clinical Journal of Pain 23(3), 197-203.
    doi: 10.1097/ajp.0b013e31802b4f6agoogle scholar: lookup
  22. Säwe J, Dahlström B, Paalzow L, Rane A. Morphine kinetics in cancer patients. Clinical Pharmacology and Therapeutics 30(5), 629-635.
    doi: 10.1038/clpt.1981.214google scholar: lookup
  23. Säwe J, Kager L, Svensson Eng JO, Rane A. Oral morphine in cancer patients: In vivo kinetics and in vitro hepatic glucuronidation. British Journal of Clinical Pharmacology 19(4), 495-501.
    doi: 10.1111/j.1365-2125.1985.tb02675.xgoogle scholar: lookup
  24. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites. Clinical and Experimental Pharmacology & Physiology 27(7), 524-528.
  25. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide-A potent antagonist of morphine analgesia. Life Sciences 47(6), 579-585.
    doi: 10.1016/0024-3205(90)90619-3google scholar: lookup
  26. Stain F, Barjavel MJ, Sandouk P, Plotkine M, Scherrmann JM, Bhargava HN. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat. Journal of Pharmacology and Experimental Therapeutics 274(2), 852-857.
  27. Thomas J, Corson NI, Meinhold A, Both CP. Neurological excitation in a 6-week-old male infant after morphine overdose. Paediatric Anaesthesia 29(10), 1060-1061.
    doi: 10.1111/pan.13723google scholar: lookup
  28. Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockmöller J. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochemical Pharmacology 86(5), 666-678.
    doi: 10.1016/j.bcp.2013.06.019google scholar: lookup
  29. van Dorp ELA, Romberg R, Sarton E, Bovill JG, Dahan A. Morphine-6-glucuronide: Morphine's successor for postoperative pain relief?. Anesthesia and Analgesia 102(6), 1789-1797.
    doi: 10.1213/01.ane.0000217197.96784.c3google scholar: lookup
  30. Vater M, Smith G, Aherne GW, Aitkenhead AR. Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers. British Journal of Anaesthesia 56(8), 821-827.
    doi: 10.1093/bja/56.8.821google scholar: lookup
  31. Yaksh TL, Wallace MS. Opioids, analgesia, and pain management. Goodman & Gilman's: The pharmacological basis of therapeutics 12th ed..

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.